Tien M Truong
2PUBLICATIONS
37CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (2)
Sort by Publication Date:
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
Pageof 1
Frequent Collaborators
2 joint publications
Laleh Amiri-Kordestani
2 joint publications
Dana Kappel
2 joint publications
William F Pierce
2 joint publications
Jingyu Yu
1 joint publications
Daniel L Suzman
1 joint publications
Mirat Shah
1 joint publications
Lijun Zhang
1 joint publications
Joyce Cheng
1 joint publications
Mary Kate Bonner
1 joint publications
Melissa Pegues